Pain following thoracotomy reduces pulmonary ventilation in man and a similar effect is believed to occur in animals. The effects of two analgesic regimens on arterial blood gas parameters were studied in dogs following thoracotomy. Postoperative analgesia was provided with intermittent nalbuphine, either alone or in combination with an intercostal nerve block using bupivacaine. Arterial blood gas analysis was carried out at 4, 8 and 16 h post-operatively, both before the administration of nalbuphine and again 30 min later. Animals which received nalbuphine alone had a significant rise in arterial oxygenation following administration of this analgesic. This effect was not observed at 4 and 8 h postoperatively in dogs which had an intercostal block with bupivacaine, but was seen at 16 h post-operatively when it could be anticipated that the effects of bupivacaine would have waned. These results suggest that intercostal block with bupivacaine can provide analgesia for over 8 h, and that the duration of action of nalbuphine in controlling post-operative pain in the dog is probably less than 4 h.
Summary
Pain following thoracotomy reduces pulmonary ventilation in man and a similar effect is believed to occur in animals. The effects of two analgesic regimens on arterial blood gas parameters were studied in dogs following thoracotomy. Postoperative analgesia was provided with intermittent nalbuphine, either alone or in combination with an intercostal nerve block using bupivacaine. Arterial blood gas analysis was carried out at 4, 8 and 16 h post-operatively, both before the administration of nalbuphine and again 30 min later. Animals which received nalbuphine alone had a significant rise in arterial oxygenation following administration of this analgesic. This effect was not observed at 4 and 8 h postoperatively in dogs which had an intercostal block with bupivacaine, but was seen at 16 h post-operatively when it could be anticipated that the effects of bupivacaine would have waned. These results suggest that intercostal block with bupivacaine can provide analgesia for over 8 h, and that the duration of action of nalbuphine in controlling post-operative pain in the dog is probably less than 4 h.
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Post-operative pain following thoracic surgery in man causes a reduction in ventilation and the consequent development of hypoxia (Buckley, Received 12 July 1990; accepted 27 February 1991 J 985). It has been reported that similar effects occur in animals (Houlton & Taylor, 1987) , but this statement appears to be based on subjective clinical assessments. We have been unable to locate any reports of controlled trials of the effects of analgesics following thoracotomy in animals, although the beneficial effects of analgesics in man are well recognized (Buckley, 1985; Alexander & Hill, 1987) .
A research programme in this laboratory required dogs to undergo unilateral lung transplantation, and necessitated monitoring of arterial blood gas parameters over the first 24 h following surgery. This series of experiments provided the opportunity to monitor the effects of analgesics following a standardized operative procedure.
In man, both systemic administration of opioids and intercostal block using local anaesthetics have been used to control pain following thoracotomy. Opioids which are currently available for clinical use in man include j), agonists, such as morphine and fentanyl, and mixed k agonist! j), antagonist such as nalbuphine and butorphanol. The J1. antagonist properties of these latter compounds is exploited in the technique originally described as 'anesthesie analgesique sequentielle' (De Castro & Viars, 1968) .Anaesthesia is maintained using a balanced anaesthetic technique, using a potent j), opioid to provide analgesia. At the end of the operative period a mixed agonist/antagonist opioid is administered. This reverses both the respiratory depressant effect and the analgesia produced by the J1. opioid, but post-operative analgesia is maintained by the action of the agonist/ antagonist at the k receptor.
We have investigated the effects of intermittent injection of nalbuphine, either alone or in combination with an intercostal nerve block using the long-acting local anaesthetic bupivacaine.
Material and methods Adult, laboratory bred beagles (body weight 13·0 ± 2· 0 kg) were obtained from a commercial supplier and housed in conventional laboratory conditions in accordance with the Home Office Code of Practice (Home Office, 1989) . A total of 18 animals were studied. No pre-anaesthetic medication was administered, but EMLA cream (Astra), a topically active local anaesthetic, was applied to the skin overlying the cephalic vein to prevent any pain on venepuncture (Flecknell et al., 1990a) . Anaesthesia was induced with propofol (6' 5 ± I . 3 mg/kg) ('Diprivan', ICI; 'Rapinovet', Coopers Pitman Moore) and maintained with a continuous infusion of propofol (0' 14 ± O' 18 mg/kg/ min) and alfentanil (2-3 p.g/ kg/min). Neuromuscular blockade was established using vecuronium (0' 1 mg/kg) ('Norcuron' , Organon-Teknika) and maintained with an additional dose of 0-05 mg/kg, which was administered following signs of re-establishment of neuromuscular function. The neuromuscular blockade was allowed to reverse spontaneously prior to closure of the thorax. Intermittent positive pressure ventilation was maintained on a Bain's coaxial circuit using a Nuffield 200 ventilator (penlon Ltd, Abingdon, UK), with an Fi02 of 400,10,tidal volume of 15 ml/kg, respiratory rate of 20 breaths/min and fresh gas flow rate of 150 ml/kg/min. Full details of the anaesthetic regimen have been described elsewhere (Fleck nell et al., 1990b) .
A left-sided thoracotomy was carried out through the fifth intercostal space to enable unilateral lung transplantation.
Full details of the surgical technique have been described elsewhere (Locke et al., 1988 ). An 18 gauge femoral artery catheter ('Leadercath', Vygon Ltd, Ecouen, France) was inserted percutaneously to monitor arterial pressure and to enable sampling of Flecknell et al. arterial blood for blood gas analysis. Bupivacaine (total volume 10 ml of a O' 50,10 solution, divided equally between the 5 intercostal spaces) (Marcaine, Astra) was injected around the intercostal nerves in the third, fourth, fifth, sixth and seventh intercostal spaces in 9 animals, prior to closure of the thorax. A second group of 9 animals acted as a control group. A thoracic drain was used to withdraw air from the thorax after the completion of surgery, and was then removed. The femoral arterial catheter was secured using an adhesive dressing and nalbuphine (10 mg total dose i/v) was administered.
After spontaneous respiration had commenced the animal was disconnected from the anaesthetic machine, extubated after recovery of laryngeal reflexes, and transferred to a recovery room.
Both groups of animals received an initial dose of nalbuphine (0' 75 mg/kg i/v) at the completion of surgery (time =: 0), followed by subsequent doses at 4, 8, 16, 20, 24 and 28 h after completion of surgery. An arterial blood sample was taken via the femoral artery catheter immediately prior to administration of the nalbuphine at 4,8 and 16 h, and a second sample taken 30 min later. The arterial catheter was removed 20 h post-operatively. An arterial blood sample was obtained at 18 h, I ml of saline administered, and a second sample taken 30 min later in 12 dogs (6 from each group). The blood samples were analysed immediately using an ABL 3000 blood gas analyser (Radiometer, Copenhagen, Denmark). All blood gas samples were obtained anaerobically using a three-way tap attached to the arterial catheter.
Arterial p02 and pC0 2 were compared in the paired samples taken before and after administration of nalbuphine (4, 8 and 16 h) or saline (18 h) in the two groups of dogs using Student's paired {-test.
Results
The arterial blood gas data are summarized in Table 1 and Figs 1 and 2. Dogs which received bupivacaine did not show any significant change in p02 or pC0 2 after administration of nalbuphine at 4 and 8 h post-operatively, but 
Values are mean ± I SO. A significant difference between the pre-and post-administration values is indicated by *(P<O'05) and "*(P< O' 01). there was a significant (P<O'05) increase in arterial oxygen tension after administration of nalbuphine at 16 h (Table I, Fig. I ). The group of animals which did not receive bupivacaine showed a significant rise in p02 after admini· stration of nalbuphine
and 16 h (P<O'OI) post-operatively (Table ] , Fig. 2 ). Arterial pC0 2 showed a significant reduction at 4 h (P< O· 05) in the group of dogs which received only nalbuphine, but did not change significantly at 8 hand ]6 h. No significant changes in pC0 2 were seen in the group of dogs which received bupivacaine and • nalbuphine ( Table 1) .
Animals which were blood sampled at ] S h post-operatively but received saline at the time .'ig. 2. Arterial pO, (mmHg) before and after the admini· stration of nalbuphine (10 mg total dose i/v) in 9 dogs following thoracotomy for unilateral lung transplantation.
Values are mean ± I SO. A significant difference between the pre-and post-administration values is indicated by *(P<O'05) and **(P<O·Ol). l!l Before nalbuphine; 0 after nalbuphine. of sampling did not show any significant change in p02 or pC0 2 when a second sample was taken 30 min later (p02 67' 3 ± 19· 7 mmHg cf 64·5±IS·lmmHg; pC0 2 30'3±1'9mmHg cf 31'1 ± 2' 3 mmHg (P>O' I), (mean ± I SO».
Discussion
In man, a number of studies have demonstrated that the provision of effective analgesia following thoracotomy has beneficial effects on pulmonary function (Kaplan et al., 1975; Toledo-Pereyra & OeMeester, 1978) . It has been assumed that a similar beneficial effect might be seen in animals (Houlton & Taylor, 1987) , although differences in the thoracic anatomy and posture in man and animals might influence both the degree of pain following thoracotomy and the effects of analgesics. In studies undertaken in man, it has been possible to correlate the effects of an analgesic regime on pulmonary function with the degree of pain relief assessed using standard scoring methods (Kaplan et at., 1975) . In animals, our current ability to assess the degree of pain is limited, and we have been unable to locate any published investigations of the degree of pain following thoracotomy in animals. One reason for this may be the difficulties entailed in collecting sufficient information from clinical cases and in particular the difficulty in obtaining a series of cases in which the nature and extent of surgery, and the breed and age of animal were carefully matched in different treatment groups. When laboratory animals are used as experimental models for surgical research, many of these variables are standardized, and such studies can provide an opportunity to investigate the effects of analgesics. Given the lack of information concerning the need for post-operative analgesia in animals, it might have been thought logical to study a group of dogs which received no analgesic therapy. This was not considered ethically acceptable by our research group, since we had formed the subjective impression that dogs required analgesics following major surgery. We therefore determined to compare two analgesic regimes, that of intermittent administration of nalbuphine and intermittent administration of nalbuphine in combination with intercostal nerve block using bupivacaine.
Nalbuphine has been suggested to be a suitable analgesic for use in the dog (Taylor, 1985) and its efficacy has been demonstrated in the rat, cat and rabbit using analgesiometry (Steinfels & Cook, 1986; Sawyer & Rech, 1987; Flecknell & Liles, 1990) . The duration of action of nalbuphine in the dog has not been established, but studies in other species suggest that it would have an analgesic effect for 3 to 6 h (Schmidt et al., 1985) . The dose rate selected was based upon that shown to be effective in experimental analgesiometry in the cat (Sawyer & Rech, 1987) and to have an anaesthetic sparing effect during enflurane anaesthesia in the dog (Murphy & Hug, 1982) . This dose was also effective in reversing the respiratory depressant effects of alfentanil, which formed part of the balanced anaesthetic regimen used in the present study (Flecknell et at., 1990b) . Nalbuphine has been shown to have a relatively minor effect on respiratory function in other animal species (Schmidt et at., 1985; Flecknell & Liles, 1990) ; and its respiratory depressant effects have been shown to plateau in man (Rosow, 1985) . We wished to avoid the use of morphine or pethidine, since it is our experience that repeated administration of these compounds following an anaesthetic regime which includes a potent fL opioid, such as alfentanil, can produce marked sedation and severe respiratory depression. We also wished to utilize the technique originally described as 'anesthesie analgesique sequentielle' (De Castro & Viars, 1968) , in which a mixed agonist-antagonist analgesic is administered to reverse the fL agonist opioid component of a balanced anaesthetic regime (Robertson & Laing, 1980; Moldenhauer et at., 1985; Flecknell et at., 1989) .
The safety of bupivacaine has been assessed in the dog (Feldman et at., 1989) , and it has been reported to be an effective long acting local anaesthetic in several animal species and in man (Buckley, 1985; Skarda, 1987; Paddleford, 1988) . There appear to be no studies of the duration of action in dogs when bupivacaine is used to provide an intercostal nerve block, but in man its effects last for 8-12 h (Buckley, 1985) . In man, it is necessary to block the intercostal nerve at the space through which the chest is entered, plus at least one, and preferably two, nerves of the spaces above and below the incision (Buckley, 1985) .
In the present study, administration of nalbuphine was shown to produce an improvement in arterial oxygenation. This effect was not observed in dogs which had an intercostal block with bupivacaine at 4 and 8 h post-operatively, but was seen at 16h post-operatively, when it • could be anticipated that the effects of bupivacaine would have waned. No attempts were made to assess the presence or absence of local Post-operative analgesia fOllowing thoracotomy in the dog 323 anaesthesia by analgesiometry. If thoracic pain causes a reduction in pulmonary ventilation in dogs by inhibiting respiratory movements, then the administration of an analgesic would be expected to improve arterial oxygen content. It seems highly unlikely that the changes observed were due either to an effect of nalbuphine unrelated to its analgesic action, or to nonspecific effects of handling and blood sampling. Nalbuphine would be expected to depress respiratory function, not improve it, and the lack of effects at 4 and 8 h post-operatively in the bupivacaine treated group suggest that a nonspecific effect was not responsible. This lack of response also suggests that handling and blood sampling were not responsible for the effects observed, and this conclusion is further supported by the lack of any significant effects when paired blood samples were taken following administration of saline at 18 h post-operatively. The effects of the analgesic regimens on blood carbon dioxide tensions were more variable. A reduction in CO 2 was seen only in dogs which had not received bupivacaine at 4 h postoperatively. It has been reported that in man, if breathing is painful, tidal volume is reduced. However, even with a reduced tidal volume carbon dioxide elimination is still effective, although oxygen uptake is relatively inefficient (Alexander & Hill, 1987) . A similar effect in dogs could account for the lack of effect of nalbuphine administration on arterial pC02• No formal pain scoring system such as that described by Morton and Griffiths (1985) was used to evaluate the dogs. Preliminary attempts to use such a system were found to produce very considerable differences of opinion between assessors. In addition, the major changes in behaviour and food and water intake which occurred as a consequence of the stress of surgery, the side effects of immunosuppressive and other drugs, as well as the effects of pain, considerably limited the number of variables that could usefully be assessed. No dog showed any signs that might be associated with severe pain, such as abnormal vocalizations, aggression when approached, or marked responses to palpation of the chest. Although it was not possible to measure tidal volume, because of the difficulties of patient compliance, several observers reported an apparent deepening of respiration following the administration of nalbuphine, but this was not a consistent finding in all dogs.
In the present study it is difficult to compare directly the overall benefits of the combination of bupivacaine and nalbuphine with the administration of nalbuphine alone. Although the surgical procedures were standardized, the degree of pulmonary dysfunction following transplantation varied very considerably between individuals. Because of this large variation and the relatively small group sizes, it was not possible to demonstrate any significant differences in blood gas parameters between the two experimental groups.
We believe that several recommendations concerning analgesia following thoracotomy in dogs can be made based on the present study. The lack of effect of nalbuphine at 4 and 8 h suggests that bupivacaine intercostal blockade provides effective analgesia for at least 8 h, but that it is no longer effective at 16 h postoperatively. The technique is simple to use, and could obviate the need for intermittent opioids for the first 8 h following surgery. Clinical monitoring of the animals for signs of pain would still be advisable. Nalbuphine appears to be effective in providing post-operative pain relief in the dog, but its duration of action appears to be less than 4 h, since after dosing at 4 h, a repeated dose at 8 h produced a significant effect on arterial oxygen. If nalbuphine is to be used as an analgesic agent in dogs, it would therefore require administration at more frequent intervals, or preferably be given by continuous infusion. Administration of post-operative analgesics by continuous infusion has been shown to provide more effective pain relief in man (Kay, 1987) and this offers a far more convenient method of maintaining effective analgesia in animals than intermittent dosing over a 24-48 h period.
